Proyeksi Harga HRTS & Analisis ETF - Dividen·Biaya Pengelolaan·Komposisi Saham·NAV·RSI·MACD | Saham AS Hari Ini
16 Okt pukul 4:00 PM ET (Korea 10/17 05:00)
Tabel metrik lengkap
| Category | Global or ExUS Equities - Industry Sector | Expense | 0.75% | Return% 1Y | 17.39% | Total Holdings | 46 | Perf Week | 1.89% | Volume | 2,359 |
| Asset Type | Equities (Stocks) | AUM | $55M | Return% 3Y | - | NAV | $37.23 | Perf Month | 1.17% | Avg Volume | 0.00M |
| ETF Type | Global Equities | Dividend TTM | $0.47 (1.28%) | Return% 5Y | - | 52W High | -5.05% | Perf Quarter | 2.78% | Rel Volume | 0.62 |
| Active/Passive | Active | Div Gr. 3/5Y | - | Return% 10Y | - | 52W Low | 15.5% | Perf Half Y | 6.54% | Prev Close | $37.23 |
| IPO | 2023/11/21 | Flows% 1M | -0.65% | Return% SI | 13.35% | RSI (14) | 55.28 | Perf YTD | 4.57% | Price | $36.90 |
| Beta | 0.65 | Flows% 3M | -0.65% | Flows% YTD | -4.35% | Flows% 1Y | -5.15% | Perf Year | 14.76% | Volatility(W/M) | 0.65% 0.74% |
| SMA20 | 1.85% | SMA50 | -0.1% | SMA200 | 4.1% | ATR | 0.46 | ||||
Tema Heart & Health ETFHRTS | NASD | Kelolaan aktif Tema Cardiovascular and Metabolic ETF seeks to provide long-term growth of capital. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.
10 terbesar mencakup 49% dari dana
LLY Eli Lilly & Co 11.52% 2 
UNH UnitedHealth Group Inc 5.24% 3 
NVO Novo Nordisk A/S 5.24% 4 
RHHBY Roche Holding AG 4.50% 5 
MRK Merck & Co Inc 4.27% 6 
AZN AstraZeneca PLC 4.00% 7 
TMO Thermo Fisher Scientific Inc 3.97% 8 
JNJ Johnson & Johnson 3.59% 9 
GILD Gilead Sciences Inc 3.43% 10 
NVS Novartis AG 3.38% Sektor dengan bobot terbesar lebih dulu.
Dalam 1 tahun terakhir, sedang
5% di bawah harga tertinggi 1 tahun.
Diperdagangkan lebih sedikit dari biasanya. Itu 62% dari volume rata-ratanya.
Kinerja jangka panjangnya cenderung datar
Ketuk untuk melihat angka
Harganya bergerak besar
Pada titik terburuk (Juli 2024) turun 26% dan butuh 231 hari untuk pulih.
Ketuk untuk melihat angka
Dividennya tergolong kecil
Membagikan dividen sebesar 1.28% per tahun.
Ketuk untuk melihat angka
Banyak uang keluar
Selama setahun terakhir, uang setara 5.2% aset keluar.
Ketuk untuk melihat angka
CURE Direxion Daily Healthcare Bull 3X ETF 186M 
RXL ProShares Ultra Health Care 2X Shares 103M 
XLVI State Street Health Care Select Sector SPDR Premium Income ETF 31M 
RXD-1× ProShares UltraShort Health Care -2x Shares 3M 
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF 3M 
DRAM Roundhill Memory ETF 0.65% 
SECT Main Sector Rotation ETF 0.69% 
AVRE Avantis Real E state ETF 0.17% 
VOLT Tema Electrification ETF 0.75% 
CANC Tema Oncology ETF 0.75% 
HAUZ Xtrackers International Real Estate ETF 0.1% 
VNQI Vanguard Global ex-U.S. Real Estate ETF 0.12% 
PBPH Portfolio Building Block World Pharma and Biotech Index ETF 0.13% 
Pertanyaan umum
Berapa jumlah saham yang dimiliki HRTS?
HRTS memiliki total 46 saham, dengan AUM sekitar $55M.
Apakah HRTS memberikan dividen (distribusi)?
Tingkat distribusi HRTS sekitar 1.28%.
Berapa tertinggi dan terendah 52 minggu HRTS?
HRTS mencatat tertinggi $38.87 dan terendah $31.95 dalam 52 minggu terakhir.
